About Tecosurf 400 (Teicoplanin for Injection IP 400 mg)
Tecosurf 400 (Teicoplanin for Injection IP 400 mg) stands as a brilliant and elite solution in the fight against severe Gram-positive bacterial infections, including formidable MRSA strains. Marketed by Hetero Healthcare Ltd., and manufactured by Welfare Pharmaceuticals Ltd., this product offers a cost-effective and bargain option for health institutions without compromising clinical efficacy. Each vial contains a towering 400 mg of Teicoplanin, conveniently provided with sterile water for injection, making reconstitution seamless. Recommended for both adults and pediatric patients under physician supervision, Tecosurf 400 delivers potent antibiotic protection in a lyophilized powder form.
Advanced Application Across Healthcare Settings
Tecosurf 400 (Teicoplanin for Injection IP 400 mg) is expertly formulated for the treatment of severe infections caused by Gram-positive bacteria, particularly in hospital and intensive care environments. Its site of action includes both systemic and localized infections requiring intravenous or intramuscular administration. With its origin in India, Tecosurf 400 supports a broad plant application, ensuring reliable supply chains to various medical facilities across the nation, empowering health professionals in critical infection management.
Sample Availability and Domestic Distribution
Tecosurf 400 samples are readily available for approved healthcare institutions, aligning with our sample policy to ensure only registered healthcare professionals have access. Packing and dispatch are meticulously handled to maintain product integrity during shipment. With a robust presence in the Indian market, we ship to major domestic regions, offering competitive market value and rapid response to supply requests. Our efficient distribution channels guarantee timely delivery and technically sound packing for maximum efficacy.
FAQ's of Tecosurf 400 (Teicoplanin for Injection IP 400 mg):
Q: How is Tecosurf 400 prepared for administration?
A: Tecosurf 400 should be reconstituted with the provided 3 ml of Sterile Water for Injection before intravenous or intramuscular use, ensuring proper dissolution under medical supervision.
Q: What are the main indications for using Tecosurf 400?
A: Tecosurf 400 is indicated for severe infections caused by Gram-positive bacteria, including MRSA, and is effective in both adult and pediatric patients as directed by a physician.
Q: When should Tecosurf 400 be administered?
A: Tecosurf 400 should be administered only after receiving a prescription from a registered medical practitioner and according to the dosage prescribed by the healthcare provider.
Q: Where can Tecosurf 400 be sourced?
A: Tecosurf 400 is supplied by Welfare Pharmaceuticals Ltd. and is available through registered suppliers, traders, and wholesalers across India.
Q: What is the process for obtaining a Tecosurf 400 sample?
A: Samples of Tecosurf 400 may be provided to registered healthcare institutions upon request, following compliance with our sample policy and domestic distribution guidelines.
Q: What are the storage requirements for Tecosurf 400?
A: Tecosurf 400 should be stored below 25C, protected from light and moisture, and used before the expiry date indicated on the packaging.